Contracts Finder

NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024

NHS England

Awarded
goods
SME-friendly
Framework agreement

Published on NHS Health Family Atamis procurement portal

This tender has closed

The submission deadline for this contract has passed. There may be more active goods tenders from NHS England, and hundreds more across the UK public sector.

Key details

Contracting authority
Region
Runcorn
Contract value
£2,015,123,000ex VAT
Submissions closed
8 December 2023
Published
3 November 2023

Procurement

Contract period
1 May 2024 - 30 April 2028
4 years
Procedure type
Open procedure (above threshold)
CPV classifications
  • 33600000 Pharmaceutical products

What happened

NHS England awarded this contract to Day Lewis Medical Ltd | Drugsrus Ltd | Neon Healthcare Ltd | Bayer Plc | ennogen healthcare ltd | Fresenius Kabi Limited | Aventis Pharma ltd t/a Sanofi | Selective Supplies Ltd. | Rosemont Pharmaceuticals Limited | Martindale Pharma | Zentiva Pharma UK Ltd | Simple Pharma | Accord-UK Ltd | B. Braun Medical Limited | Janssen-Cilag Ltd | GlaxoSmithKline UK Limited | Roche Products Ltd | Pfizer Ltd | ORPHALAN UK LTD | Merck Sharpe & Dohme (UK) Limited | Flexipharm Austrading Limited | FLYNN PHARMA LTD | Aguettant Ltd | Mercury Pharmaceuticals Limited | Abbvie Ltd | Clinigen Healthcare Limited | Thornton and Ross Ltd | Sun Pharma UK Ltd | Valneva UK Ltd | Venture Healthcare Ltd | Glenmark Pharmaceuticals Europe Limited | Dexcel Pharma Ltd | Alan Pharmaceuticals | AOP Orphan Ltd | Brancaster Pharma Ltd | Stirling Anglian Pharmaceuticals Ltd | Ferndale Pharmaceuticals Ltd | Aspen Pharmacare UK Limited | Univar Solutions | Napp Pharmaceuticals Ltd | Morningside Pharmaeuticals | Kyowa Kirin Ltd | Biovantic Pharma Limited | Alliance Pharmaceuticals Limited | CST Pharma Limited | Waymade PLC | Biofrontera Pharma GmbH | Novartis Pharmaceuticals UK Ltd | Reckitt Benckiser | Teva UK Limited | Dr Falk Pharma UK Ltd | Novo Nordisk | Amarox Limited | Bausch + Lomb (Pharma) | Fontus Health Ltd | A. Menarini Farmaceutica Internazionale SRL | Recordati Rare Diseases UK Ltd | Aspire Pharma Limited | Ferring Pharmaceuticals Ltd | Chiesi Limited | SERB SA | Sandoz Ltd | Amgen Ltd | Cipla (EU) Ltd | Colonis Pharma Ltd | Cenote Pharma Limited | AstraZeneca | Necessity Supplies Limited | Takeda UK Ltd | PARI | Tillotts Pharma UK Ltd | Lupin Healthcare (UK) Limited | Thea Pharmaceuticals Limited | Essential Pharma | Wockhardt UK Limited | Merck Serono Limited | Evolan Pharma | Organon Pharmaceuticals UK Ltd | Tillomed Laboratories ltd | Xiromed | Eli Lilly & Company Ltd | Pharmacosmos UK Ltd | Luye Pharma Ltd | Uni Health Distribution Ltd | Crescent Pharma Ltd | Focus Pharmaceuticals Ltd worth £1,009,500,000 on 5 Apr 2024. The contract runs until 30 Apr 2028.

Description

NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024

Offer reference number: CM/PHR/22/5682

CM/PHR/22/5682/01 - NHS Framework Agreement for Branded Medicines - National Tender - Lot 1. Period of framework: 1 May 2024 to 30 April 2028.

CM/PHR/22/5682/02 - NHS Framework Agreement for Branded Medicines - National Tender - Lot 2. Period of framework: 1 May 2024 to 30 April 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Awarded suppliers (90)

Suppliers
  • Day Lewis Medical Ltd
  • Drugsrus Ltd
  • Neon Healthcare Ltd
  • Bayer Plc
  • ennogen healthcare ltd
  • Fresenius Kabi Limited
  • Aventis Pharma ltd t/a Sanofi
  • Selective Supplies Ltd.
  • Rosemont Pharmaceuticals Limited
  • Martindale Pharma
  • Zentiva Pharma UK Ltd
  • Simple Pharma
  • Accord-UK Ltd
  • B. Braun Medical Limited
  • Janssen-Cilag Ltd
  • GlaxoSmithKline UK Limited
  • Roche Products Ltd
  • Pfizer Ltd
  • ORPHALAN UK LTD
  • Merck Sharpe & Dohme (UK) Limited
  • Flexipharm Austrading Limited
  • FLYNN PHARMA LTD
  • Aguettant Ltd
  • Mercury Pharmaceuticals Limited
  • Abbvie Ltd
  • Clinigen Healthcare Limited
  • Thornton and Ross Ltd
  • Sun Pharma UK Ltd
  • Valneva UK Ltd
  • Venture Healthcare Ltd
  • Glenmark Pharmaceuticals Europe Limited
  • Dexcel Pharma Ltd
  • Alan Pharmaceuticals
  • AOP Orphan Ltd
  • Brancaster Pharma Ltd
  • Stirling Anglian Pharmaceuticals Ltd
  • Ferndale Pharmaceuticals Ltd
  • Aspen Pharmacare UK Limited
  • Univar Solutions
  • Napp Pharmaceuticals Ltd
  • Morningside Pharmaeuticals
  • Kyowa Kirin Ltd
  • Biovantic Pharma Limited
  • Alliance Pharmaceuticals Limited
  • CST Pharma Limited
  • Waymade PLC
  • Biofrontera Pharma GmbH
  • Novartis Pharmaceuticals UK Ltd
  • Reckitt Benckiser
  • Teva UK Limited
  • Dr Falk Pharma UK Ltd
  • Novo Nordisk
  • Amarox Limited
  • Bausch + Lomb (Pharma)
  • Fontus Health Ltd
  • A. Menarini Farmaceutica Internazionale SRL
  • Recordati Rare Diseases UK Ltd
  • Aspire Pharma Limited
  • Ferring Pharmaceuticals Ltd
  • Chiesi Limited
  • SERB SA
  • Sandoz Ltd
  • Amgen Ltd
  • Cipla (EU) Ltd
  • Colonis Pharma Ltd
  • Cenote Pharma Limited
  • AstraZeneca
  • Necessity Supplies Limited
  • Takeda UK Ltd
  • PARI
  • Tillotts Pharma UK Ltd
  • Lupin Healthcare (UK) Limited
  • Thea Pharmaceuticals Limited
  • Essential Pharma
  • Wockhardt UK Limited
  • Merck Serono Limited
  • Evolan Pharma
  • Organon Pharmaceuticals UK Ltd
  • Tillomed Laboratories ltd
  • Xiromed
  • Eli Lilly & Company Ltd
  • Pharmacosmos UK Ltd
  • Luye Pharma Ltd
  • Uni Health Distribution Ltd
  • Crescent Pharma Ltd
  • Focus Pharmaceuticals Ltd
  • Esteve Pharmaceuticals Ltd
  • Typharm Ltd
  • RPH Pharmaceuticals AB
  • Tetris Pharma Lts
Award value
£1,009,500,000
Award date
5 April 2024

Contact

Address
2nd Floor Rutland House, Runcorn, WA7 2ES
Contact name
Lynne Tierney

Identifiers

Buyer reference
CF-2342700D0O000000rwimUAA
Notice ID
a52f2080-c2fd-4856-b230-15ecd887e278-746786
OCID
ocds-b5fd17-44e0652a-0ec7-4c96-8783-61205dae8a30

Explore related tenders

External ID: cf-ocds-b5fd17-44e0652a-0ec7-4c96-8783-61205dae8a30 • Added 3 October 2026